# Drug Interaction Study of Digoxin and BI 10773

> **NCT01306175** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Digoxin plus BI 10773
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT01306175
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-04
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306175, "Drug Interaction Study of Digoxin and BI 10773". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01306175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*